[Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003523:Cycloserine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007391:International Cooperation; D008297:Male; D008875:Middle Aged; D011718:Pyrazinamide / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D011718:Pyrazinamide; D003523:Cycloserine; D005000:Ethionamide
Wyniki leczenia skojarzeniami trzech leków zastepczych przewlekłej, jamistej gruźlicy płuc w ramach badan Miedzynarodowej Unii Przeciwgruźliczej.